Iconiq Capital’s Relay Therapeutics RLAY Stock Holding History

Iconiq Capital’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Hold	94,697	–	–	0.05%	44
2026 Q1	$942K	Hold	94,697	–	–	0.02%	52
2025 Q4	$801K	Hold	94,697	–	–	0.01%	59
2025 Q3	$494K	Hold	94,697	–	–	0.01%	73
2025 Q2	$328K	Hold	94,697	–	–	0.01%	266
2025 Q1	$248K	Hold	94,697	–	–	﹤0.01%	319
2024 Q4	$390K	Hold	94,697	–	–	0.01%	189
2024 Q3	$670K	Hold	94,697	–	–	0.01%	74
2024 Q2	$617K	Hold	94,697	–	–	0.01%	57
2024 Q1	$786K	Hold	94,697	–	–	0.01%	47
2023 Q4	$1.04M	Hold	94,697	–	–	0.02%	45
2023 Q3	$796K	Hold	94,697	–	–	0.02%	44
2023 Q2	$1.19M	Hold	94,697	–	–	0.02%	40
2023 Q1	$1.56M	Hold	94,697	–	–	0.02%	40
2022 Q4	$1.41M	Hold	94,697	–	–	0.02%	40
2022 Q3	$2.12M	Hold	94,697	–	–	0.03%	36
2022 Q2	$1.59M	Hold	94,697	–	–	0.02%	44
2022 Q1	$2.83M	Hold	94,697	–	–	0.02%	42
2021 Q4	$2.91M	Hold	94,697	–	–	0.02%	48
2021 Q3	$2.99M	Hold	94,697	–	–	0.02%	44
2021 Q2	$3.46M	Hold	94,697	–	–	0.02%	39
2021 Q1	$3.27M	Hold	94,697	–	–	0.04%	30
2020 Q4	$3.94M	Hold	94,697	–	–	0.1%	34
2020 Q3	$4.03M	Buy	+94,697	New	+$3.61M	0.23%	34

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Iconiq Capital's RLAY Position: Q2 2026 in Review

Iconiq Capital held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 94,697 shares worth $1.77M. The position accounts for 0.05% of the portfolio, ranked #44.

Iconiq Capital first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.03M in Q3 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Iconiq Capital held 94,697 shares of Relay Therapeutics worth $1.77M as of Q2 2026.
Iconiq Capital left its Relay Therapeutics share count unchanged in Q2 2026.
Relay Therapeutics made up 0.05% of Iconiq Capital's portfolio in Q2 2026, its #44 holding.
Iconiq Capital first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
Iconiq Capital's Relay Therapeutics position peaked at $4.03M in Q3 2020.
258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Iconiq Capital's 13F filing for Q2 2026, filed 13 Aug 2026.